Available to SourceHuman Prescription DrugOncology & Specialty

Xalkori (Crizotinib)

20 mg/1 · Capsule Coated Pellets

By Pfizer Laboratories Div Pfizer Inc

Crizotinib · Capsule, Coated Pellets · 20 mg

NDC: 0069-0251
Route: Oral
Therapeutic class: Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor , Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]
Marketing category: NDA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Oncology & Specialty

See all →

Xalkori (Crizotinib)

Additional information

Request this medication.

Related in Oncology & Specialty

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)